Current and future prospective of caspases targeting in cancer therapy
Author:
Publisher
Elsevier
Reference68 articles.
1. Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis;Abdulghani;PLoS One,2013
2. Celastrol enhances TRAIL-R2-mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase-dependent manner;Bao;Oncology Reports,2024
3. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model;Buchsbaum;Clinical Cancer Research,2003
4. American cancer society,2023
5. YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway;Chang;Journal of Hematology & Oncology,2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3